Looks like Sofinnova Ventures is bulking up one of its venture funds – up from $50 million a year ago to $110 million today.
About $65 million of the Sofinnova HealthQuest Partners fund has been sold, with $45 million still remaining, according to the updated filing.
The venture firm is one of the oldest, with roots dating back to the early ’70s. Sofinnova has branches in the Bay Area, San Diego and Ireland, and focuses on funding both life sciences and technology startups.
Sofinnova Ventures has a robust active portfolio. Some of its more notable funding rounds include participation in a $72.8 million Series B round with Spark Therapeutics, a $55 million C round with Coherus Bio Sciences and a $50 million round with Principia Biopharma.
Calls for comment on the updated Sofinnova fund were not returned.
